US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013

First Page		Document Content
Combination drugs GlaxoSmithKline Chronic lower respiratory diseases Alcohols Fluticasone/salmeterol Chronic obstructive pulmonary disease Formoterol Budesonide/formoterol Salmeterol Pulmonology Medicine Respiratory therapy		US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 719,91 KB Share Document on Facebook

	DOC Document DocID: 1rs8N - View Document
	Microsoft WordSpiriva final redline new IFU.docx DocID: 1rn7z - View Document
	The Dangers to Health from Health Effects of Wood Smoke Exposures W DocID: 1rkGG - View Document
	Statement of Israel Rappaport Before the House Committee on Interstate and Foreign Commerce on Bills Relating to Cigarette Labeling and Advertising DocID: 1rc0I - View Document
	Microsoft Word - NATA diesel 2002 health imapcts.doc DocID: 1qQte - View Document